✦ LIBER ✦

107-P: CD8+ T-cell responses to peptides derived from PRAME occur in patients with acute myelogenous leukemia and in healthy donors

✍ Scribed by Rhoda B. Eniafe; Katayoun Rezvani; A. John Barrett

Book ID: 116531638
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 45 KB
Volume: 68
Category: Article
ISSN: 0198-8859
DOI: 10.1016/j.humimm.2007.08.130

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p21-ras-peptide-specific T-cell response

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)

✍ Beate Fossum; Tobias Gedde-Dahl III; Jarle Breivik; Jon Amund Eriksen; Anne Spur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 979 KB

Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p2I ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with mu

IL-12p70 and IL-18 gene-modified dendrit

IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro

✍ Vujanovic, L; Ranieri, E; Gambotto, A; Olson, W C; Kirkwood, J M; Storkus, W J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB